Drug Screening Laboratory Services Market Overview:
The global drug screening laboratory services market size was valued at $6,720 million in 2019, and is projected to reach $7,050 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.
Drug screening tests examine biological samples such as blood, hair, & urine to detect substance addiction or its metabolites in the body of a patient. Drug screening tests are used to evaluate if a person is or was under the influence of a drug or drugs at a certain point of time. It is a quick and painless technical analysis. Drug screening devices have improved, leading to implementation of emerging technologies that offer reliable and accurate results for consumers. Employers implement drug screening tests to maintain a safe, clean, and healthy workforce, which helps to increase high productivity and a suitable work environment.
Growth of the global drug screening laboratory services market is majorly driven by surge in awareness against drug abuse and stringent government regulations regarding drug abuse. In addition, rise in in funding for drug screening is anticipated to drive growth of drug screening products in the future. However, consideration of drug screening as a violation of rights and impact of COVID-19 pandemic on the drug screening services restricts the market growth On the contrary, development of novel drug screening tests and tapping emerging markets are expected to provide significant profitable opportunities for manufacturers in the drug screening laboratory services industry.
COVID-19 pandemic, which started from Wuhan city of China, has widespread across the globe. The pandemic has negatively affected the drug screening laboratory market, owing to adoption of lockdown across the globe. The pandemic has led to a number of workplace shut-downs and quarantines. Moreover, all sectors including transport, retail, and oil & gas are experiencing a slowdown in business, owing to the pandemic, which, in turn, has affected the drug screening laboratory services market. In addition, not much new jobs are generating in the pandemic and pre-employment drug testing services are majorly hampered. Drug screening service providers are also experiencing lesser demand for screening services from employers during this pandemic, which, in turn, restricts the drug screening laboratory services market growth.
The drug screening laboratory services market is segmented into service type, sample type, end user, and region. On the basis of service type, the market is categorized into workplace drug testing and clinical toxicology. By sample type, it is further divided into urine, oral fluid, breath, hair, and others. On the basis of end user, it is divided into retail, oil & gas, transportation, staffing, government, other workplaces, hospital laboratories, clinical laboratories, and other laboratories. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Service Type segment review
By service type, the workplace segment dominated the global drug screening laboratory services market in 2019, and is anticipated to continue this trend during the forecast period. The key factors that drive the market growth include increase in use of drugs and alcohol consumption by employees, which compels organizations to carry out regular drug tests.
Workplace segment held the dominant position in 2019 and would continue to maintain the lead over the forecast period.
Sample type segment review
By sample, the urine sample segment accounted for majority of the drug screening laboratory services market share in 2019, owing to rise in adoption of point of care drug screening, rapid & easy drug screening, and detection multiple drug abuses in one test. The hair sample segment is expected to be the fastest growing segment from 2020 to 2027, owing to benefits such as non-invasive nature, low risk of sample tampering, and shorter detection window.
North America accounted for majority of the market share of the global drug screening laboratory services market in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to rise in use of alcohol and illicit drugs at workplaces, higher adoption of drug screening products, rise in government funding for drug testing, and increase in demand for new drug testing technologies such as fuel cell breath analyzers. On the other side, Europe is expected to experience highest growth rate during the forecast period, majorly owing to increase in prevalent incidences of drug abuse & drug addiction, rise in healthcare reforms, and technological advancements in the field of healthcare.
Hair segment is projected as one of the most lucrative segments.
Some of the key players operating in the drug screening laboratory services market include Abbott Laboratories (Alere Inc.), Quest Diagnostics Incorporated., Clinical Reference Laboratory, Inc, Laboratory Corporation of America Holdings, Sterling Healthcare Opco, Llc/Cordant Health Solutions, Acm Global Laboratories, Inc, Omega Laboratories, Psychemedics, Millennium Health, Mayo Foundation For Medical Education and Research, and Precision Diagnostics.
North America region would exhibit the highest CAGR of 11.3% during the forecast period.
Key Benefits for Stakeholders:
- The study provides an in-depth analysis of the global drug screening laboratory services market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the drug screening laboratory services market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing drug screening laboratory services market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of drug screening used across the globe.
- Key market players and their strategies have been analysed to understand the competitive outlook of the market.
Drug Screening Laboratory Services Market Report Highlights
By Service Type
By Sample Type
By End User
Key Market Players
LABORATORY CORPORATION OF AMERICA HOLDINGS, MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, MILLENNIUM HEALTH, OMEGA LABORATORIES LIMITED, QUEST DIAGNOSTICS INCORPORATED, PRECISION DIAGNOSTICS, PSYCHEMEDICS CORPORATION, ABBOTT LABORATORIES (ALERE), CLINICAL REFERENCE LABORATORY, INC, STERLING HEALTHCARE OPCO, LLC/CORDANT HEALTH SOLUTIONS, ACM GLOBAL LABORATORIES, INC
Drug screening test uses biological samples such as urine, blood, saliva, and hair to detect the presence of drugs and drug metabolites in a person. In addition, drug screening laboratory services are increasingly being adopted by employers, and several other end users.
Moreover, increase in consumption of alcohol & illicit drugs across the globe is one of the major drivers for the drug screening market. In addition, technological advancements toward development of accurate drug screening tests, enforcement of stringent laws mandating drug & alcohol testing, rise in product launches & services, increase in awareness on drug screening policy, and rise in government funding & initiatives for drug testing fuel growth of the global drug screening market.
Furthermore, North America is expected to remain dominant during the forecast period, owing to rise in cases of drug consumption, increase in adoption of drug screening services by employers, and presence of various key providers of drug screening services. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, owing to rise in incidences of drug abuse & drug addiction, and rise in government funding for drug testing.